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The physiological process of ageing is characterized by an 
increase in visceral fat, insulin resistance, immune senescence and 
sarcopenia. We hypothesize that iNKT cells, a regulatory type of T-
cells, play an important role in this ageing process. The arguments 
supporting this hypothesis are given here. Moreover, chemical and 
biological characterization of known iNKT activators is presented 
by a clustering dendrogram. This allows us to more efficiently 
design novel activators with biased immune-modulating properties 
and to investigate their effect on muscle mass and function. As 
such, our findings will contribute to an improved 
pathophysiological understanding of sarcopenia from an 
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CONCLUSION iNKT IN AGEING PROCESSES 
Figure 3. An illustration of the physico-
chemical hierarchical cluster analysis (HCA) 
analysis of the currently known iNKT 
activators. 
MODULATING iNKT RESPONSE 
iNKT cells in a flash 
     1 + 2 + 3 + 4   
=> Hypothesis: iNKT cells play an important role in sarcopenia 
=> modulating iNKT responses will influence the disease progression. 
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Figure 2. Interaction of APC with iNKT.  
1. Visceral fat and iNKT 
Recent data points to an important crosstalk between visceral fat and iNKT cells: 
  iNKT cells are present in adipose tissue, both in mice and men. 
  iNKT cells become activated by adipocytes and dietary lipid excess. 
  iNKT knock-out mice have a changed adiposity and adipose tissue inflammation.   
2. Insulin resistance and iNKT 
The well-known link between obesity and insulin resistance is (partly) mediated via iNKT cells: 
  evidence for functional crosstalk between adipocytes and iNKT cells (see above). 
  iNKT knock-out mice can suppress insulin resistance in early-stage obesity.  
3. Immune senescence and iNKT 
Ageing is associated with a dysregulation of the immune system: basal low-grade 
inflammation (inflammaging) as well as impaired activation when stimulated. iNKT cells are 
known to participate in this immune senescence: 
 the quantity of iNKT cells declines with ageing in human blood and liver. 
 there is an increase of iNKT cells with ageing in spleen and lymph nodes. 
 iNKT cells from aged mice have a different cytokine-profile in response to infection 
compared with young iNKT cells. 
4. Sarcopenia and iNKT 
Sarcopenia is strongly related to visceral obesity, insulin resistance and immune senescence: 
 lipotoxicity and adipokines lead to a declined proteïn synthesis in muscle cells. 
 non-diabetic obese rats develop resistance to insulin’s anti-proteolytic actions 
compared to non-diabetic lean rats. 
 myokines, e.g. IL-15, may play a role in immune senescence, more specific the NK 
cell dysregulation. 
 TNFα and IL-6, pro-inflammatory cytokines, augment with ageing, negatively 
affecting muscle tissue.  
• T-cells with a restricted/semi-
invariant TCR: Vα14-Jα18 in mice 
and Vα24-Jα18 in human. 
• Recognize glycolipid antigens on 
the MHC I-like molecule CD1d, 
presented by APC’s. 
• High and rapid cytokine production 
on activation. 
• α-GalCer glycolipid is the prototype 
of strong iNKT activators. 
• Modified glycolipids can strongly 
bias the cytokine-profile.  
• They play a role in auto-immune 
diseases, infections and cancer . 
We need strong iNKT activators that elicit a specific biased immune-
response. To support this search, the physico-chemical and biological 
properties of the currently known iNKT activators were investigated. With 
a computational in-silico approach, we characterized these iNKT 
activators in order to fuse these two information-sets.   
 
Figure 1. Visercal obesity, insulin resistance, immune senescence and sarcopenia: 
strongly associated processes. iNKT cells play an important role in the first 3 
processes. We speculate that  also in sarcopenia, iNKT cells are crucial in the 
pathophysiology.  
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